Preliminary experiments suggest conolidine could inhibit specific ion channels, minimizing neuronal excitability and restricting pain alerts. This mechanism is especially relevant in neuropathic ache, in which abnormal signaling brings about persistent discomfort. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways i